Radioactive tracer seeks out hidden cancer cells
NCT ID NCT05892393
Summary
This early-stage study is testing a new radioactive tracer called [89Zr]DFO-YS5 for PET scans in patients with multiple myeloma. The tracer is designed to attach to a specific protein (CD46) found on myeloma cancer cells, potentially helping doctors see the cancer more clearly. Researchers will compare this new scan to standard PET scans in 20 participants to see if it's safe and if it can detect cancer better.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94143, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.